Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025

移植診断の世界市場予測:技術別(PCR、NGS、サンガーシーケンス)、製品別(機器、試薬、ソフトウェア)、用途別(HLA、血液像、病原体検出)、種類別(心臓、腎臓、肝臓、骨髄)、エンドユーザー別(病院)

◆タイトル:Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025
◆商品コード:MD 4870
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年2月28日
◆ページ数:228
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は移植診断の世界市場が、2020年68億ドルから2025年90憶ドルまで、年平均5.6%成長すると予測しています。本調査レポートでは、移植診断の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、技術別(PCR、NGS、サンガーシーケンス)分析、製品&サービス別(試薬&消耗品、機器、ソフトウェア&サービス)分析、用途別(HLA、血液像、病原体検出)分析、移植種類別(固形臓器移植、幹細胞移植、軟組織移植、骨髄移植)分析、エンドユーザー別(独立型研究賞、病院&移植センター、研究所&学術機関)分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・移植診断の世界市場:技術別(PCR、NGS、サンガーシーケンス)
・移植診断の世界市場:製品&サービス別(試薬&消耗品、機器、ソフトウェア&サービス)
・移植診断の世界市場:用途別(HLA、血液像、病原体検出)
・移植診断の世界市場:移植種類別(固形臓器移植、幹細胞移植、軟組織移植、骨髄移植)
・移植診断の世界市場:エンドユーザー別(独立型研究賞、病院&移植センター、研究所&学術機関)
・移植診断の世界市場:地域別
・競争状況
・企業概要

“The global transplant diagnostics market is projected to grow at a CAGR of 7.2% during the forecast period.”
The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. The demand for transplant diagnostic products is expected to grow due to technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities. The transplant diagnostics market is segmented on product, technology, application, transplant type, end user, and region.

“The independent reference laboratories segment accounted for the largest share of the transplant diagnostics market, by end user, in 2019.”
Based on end user, the transplant diagnostics market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the transplant diagnostics market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

“The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019.”
The transplant diagnostics market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.

“North America accounted for the largest share of the transplant diagnostics market in 2019.”
North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
• By Designation: C-level (10%), Director-level (14%), and Others (76%)
• By Region: North America (40%), Europe (32%), APAC (20%), and RoW (8%)

Some of the prominent players in the transplant diagnostics market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), bioMérieux (France), Becton, Dickinson and Company (US), and Omixon (Hungary).

Research Coverage
This report studies the transplant diagnostics market based on product, technology, application, transplant type, end user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the transplant diagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 25)
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Secondary Sources
2.1.2 Primary Research
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Procedure-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary (Page No. – 34)

4 Premium Insights (Page No. – 40)
4.1 Transplant Diagnostics Market Overview
4.2 Market, By Technology
4.3 Regional Analysis: Market, By Application
4.4 Asia Pacific: Market, By End User, 2019
4.5 Regional Analysis: Market, By Product & Service
4.6 Regional Analysis: Market, By Transplant Type
4.7 Market, By Country

5 Market Overview (Page No. – 47)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Increasing Number of Transplant Procedures
5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics
5.2.1.3 Increasing Public-Private Funding for Target Research Activities
5.2.1.4 Increasing Prevalence of Infectious Diseases
5.2.2 Key Market Restraints
5.2.2.1 High Procedural Cost of Ngs- and Pcr-Based Diagnostic Assays
5.2.2.2 Limited Reimbursements for Target Procedures
5.2.3 Key Market Opportunities
5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation
5.2.3.2 Growing Public Awareness About Organ Donation and Transplantation
5.2.4 Key Market Challenges
5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually
5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Technology (Page No. – 55)
6.1 Introduction
6.2 Molecular Assay Technologies
6.2.1 Pcr-Based Molecular Assays
6.2.1.1 Sequence-Specific Oligonucleotide-Pcr
6.2.1.1.1 Sso-Pcr is the Most Widely Adopted Technique in the Pcr-Based Molecular Assays Market
6.2.1.2 Sequence-Specific Primer-Pcr
6.2.1.2.1 Growing Public-Private Investments for Research Activities to Support Market Growth
6.2.1.3 Real-Time Pcr
6.2.1.3.1 Real-Time Pcr Requires Smaller Sample Volumes As Compared to Conventional Pcr Technologies
6.2.1.4 Other Pcr-Based Molecular Assays
6.2.2 Sequencing-Based Molecular Assays
6.2.2.1 Sanger Sequencing
6.2.2.1.1 Sanger Sequencing Segment to Register the Highest Growth in the Sequencing-Based Molecular Assays Market
6.2.2.2 Next-Generation Sequencing
6.2.2.2.1 Low Turnaround Time & High Throughput Sequencing are the Major Factors Supporting the Adoption of Ngs
6.2.2.3 Other Sequencing-Based Molecular Assays
6.3 Non-Molecular Assay Technologies
6.3.1 Replacement of Non-Molecular Assay Techniques With Dna-Based Techniques is Expected to Hamper Market Growth

7 Transplant Diagnostics Market, By Product & Service (Page No. – 73)
7.1 Introduction
7.2 Reagents & Consumables
7.2.1 Reagents & Consumables—the Largest & Fastest-Growing Segment in the Market
7.3 Instruments
7.3.1 Increasing Public-Private Investments Will Support Market Growth
7.4 Software & Services
7.4.1 Growing Automation & Digitalization of Diagnostic Laboratory Procedures are Supporting Market Growth

8 Transplant Diagnostics Market, By Application (Page No. – 78)
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Pre-Transplantation Diagnostics
8.2.1.1 Infectious Disease Testing
8.2.1.1.1 Growing Adoption of Advanced Molecular Techniques for Pathogen Detection to Drive Market Growth
8.2.1.2 Histocompatibility Testing
8.2.1.2.1 Technological Advancements and Growing R&D Activities Indicate Strong Growth Potential in This Segment
8.2.1.3 Blood Profiling
8.2.1.3.1 Growing Availability of Molecular Assay Products has Supported Market Growth
8.2.2 Post-Transplantation Diagnostics
8.2.2.1 Greater Risk of Disorders & Infections Post-Transplantation Makes Diagnostics A Necessary Step
8.3 Research Applications
8.3.1 Growing Funding for Research has Driven Market Growth

9 Transplant Diagnostics Market, By Transplant Type (Page No. – 86)
9.1 Introduction
9.2 Solid Organ Transplantation
9.2.1 Kidney Transplantation
9.2.1.1 Market Growth is Mainly Driven By Rising Kidney Disease Prevalence
9.2.2 Liver Transplantation
9.2.2.1 Growing Patient Population With Chronic Liver Diseases and Increasing Procedural Volume are the Key Indicators of Market Growth
9.2.3 Lung Transplantation
9.2.3.1 Rising Prevalence of Chronic Lung Disease is A Key Growth Driver of This Market Segment
9.2.4 Heart Transplantation
9.2.4.1 Rising Procedural Volume Indicates Strong Growth Prospects
9.2.5 Pancreas Transplantation
9.2.5.1 Procedural Complexity and the Risk of Surgical Complications Have Restrained the Demand for Market Products in This Segment
9.2.6 Other Organ Transplantations
9.3 Stem Cell Transplantation
9.3.1 Rising Procedural Volume and Growing Research Activities are Driving the Growth of the Market
9.4 Soft Tissue Transplantation
9.4.1 Technological Advancements and Rising Prevalence of Target Diseases Have Driven Market Growth
9.5 Bone Marrow Transplantation
9.5.1 Dearth of Well-Trained Surgeons to Perform Bone Marrow Transplantation is Expected to Hinder Market Growth

10 Transplant Diagnostics Market, By End User (Page No. – 98)
10.1 Introduction
10.2 Independent Reference Laboratories
10.2.1 Rising Consolidation of Diagnostic Laboratories to Drive Market Growth
10.3 Hospitals & Transplant Centers
10.3.1 Growing Purchasing Power of Hospitals & Transplant Centers has Resulted in High Market Growth
10.4 Research Laboratories & Academic Institutes
10.4.1 Growing Awareness About the Genetic Techniques in Transplant Rejection Monitoring to Drive Market Growth

11 Transplant Diagnostics Market, By Region (Page No. – 104)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 Ongoing Technological Advancements in the Field of Transplant Diagnostics to Drive Market Growth in the US
11.2.2 Canada
11.2.2.1 Growing Availability of Transplant Diagnostic Products to Support Market Growth in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Germany Accounted for the Largest Share of the European Market
11.3.2 UK
11.3.2.1 Rising Number of Transplantation Procedures to Drive Market Growth in the UK
11.3.3 France
11.3.3.1 Adoption of Molecular Diagnostic Techniques for Donor-Recipient Compatibility Testing is Increasing in France
11.3.4 Spain
11.3.4.1 Rising Number of Solid Organ Transplantation Procedures to Drive Market Growth in Spain
11.3.5 Italy
11.3.5.1 Sluggish Growth in the Italian Healthcare Sector in the Last Few Years to Restrain Market Growth
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.1.1 Healthcare Infrastructural Improvements to Support Market Growth in China
11.4.2 India
11.4.2.1 Increasing Number of Transplantation Procedures to Drive Market Growth in India
11.4.3 Japan
11.4.3.1 Significant Growth in Chronic Disease Prevalence to Support Market Growth in Japan
11.4.4 Australia
11.4.4.1 Rising Number of Solid Organ Transplantation Procedures to Support Market Growth in Australia
11.4.5 South Korea
11.4.5.1 Government Initiatives to Introduce Medical Coverage for Transplantation to Support Market Growth in South Korea
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.1.1 Brazil Accounted for the Largest Share of the Latam Market
11.5.2 Mexico
11.5.2.1 Rising Medical Tourism to Support Market Growth in Mexico
11.5.3 Rest of Latam
11.6 Middle East & Africa

12 Competitive Landscape (Page No. – 151)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Product Launches & Enhancements
12.3.2 Agreements, Partnerships, and Collaborations
12.3.3 Acquisitions
12.3.4 Expansions
12.4 Competitive Leadership Mapping
12.4.1 Visionary Leaders
12.4.2 Innovators
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies

13 Company Profiles (Page No. – 158)
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 Becton, Dickinson and Company
13.2 Biofortuna
13.3 Biomérieux SA
13.4 Bio-Rad Laboratories
13.5 Caredx
13.6 F. Hoffman-La Roche Limited
13.7 Gendx
13.8 Hologic, Inc.
13.9 Illumina, Inc.
13.10 Immucor, Inc.
13.11 Luminex Corporation
13.12 Merck KGaA
13.13 Omixon
13.14 Qiagen Nv
13.15 Thermo Fisher Scientific
13.16 Emerging Players
13.16.1 Alpha Biotech, Ltd.
13.16.2 Bag Healthcare
13.16.3 Hansa Biopharma AB
13.16.4 Histogenetics LLC
13.16.5 Pacific Biosciences of California, Inc.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 209)
14.1 Discussion Guide
14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details

List of Tables (153 Tables)

Table 1 Public-Private Investments and Research Grants for the Development of Transplant Diagnostic Products, 2015–2018
Table 2 Cost of Assays for Major Ngs/Pcr-Based Genomic Tests in Europe (As of 2017)
Table 3 Medical Reimbursements for Transplantation Procedures in the US (2017)
Table 4 Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 5 Market for Molecular Assay Technologies, By Type, 2017–2025 (USD Million)
Table 6 Market for Molecular Assay Technologies, By Product, 2017–2025 (USD Million)
Table 7 Market for Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 8 Market for Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 9 Market for Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 10 Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 11 Market for Pcr-Based Molecular Assays, By Product, 2017–2025 (USD Million)
Table 12 Market for Pcr-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 13 Market for Pcr-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 14 Market for Pcr-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 15 Market for Sequence-Specific Oligonucleotide-Pcr, By Region, 2017–2025 (USD Million)
Table 16 Market for Sequence-Specific Primer-Pcr, By Region, 2017–2025 (USD Million)
Table 17 Market for Real-Time Pcr, By Region, 2017–2025 (USD Million)
Table 18 Market for Other Pcr-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 19 Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 20 Market for Sequencing-Based Molecular Assays, By Product, 2017–2025 (USD Million)
Table 21 Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 22 Market for Sequencing-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 23 Market for Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 24 Market for Sanger Sequencing, By Region, 2017–2025 (USD Million)
Table 25 Market for Next-Generation Sequencing, By Region, 2017–2025 (USD Million)
Table 26 Market for Other Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 27 Market for Non-Molecular Assay Technologies, By Product, 2017–2025 (USD Million)
Table 28 Market for Non-Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 29 Transplant Diagnostics Market for Non-Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 30 Market for Non-Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 31 Market, By Product & Service, 2017–2025 (USD Million)
Table 32 Market for Reagents & Consumables, By Region, 2017–2025 (USD Million)
Table 33 Market for Instruments, By Region, 2017–2025 (USD Million)
Table 34 Market for Software & Services, By Region, 2017–2025 (USD Million)
Table 35 Market, By Application, 2019–2025 (USD Million)
Table 36 Market for Diagnostic Applications, By Type, 2019–2025 (USD Million)
Table 37 Market for Diagnostic Applications, By Region, 2019–2025 (USD Million)
Table 38 Pre-Transplantation Diagnostics Market, By Type, 2019–2025 (USD Million)
Table 39 Pre-Transplantation Diagnostics Market, By Region, 2019–2025 (USD Million)
Table 40 Infectious Disease Testing Applications Market, By Region, 2019–2025 (USD Million)
Table 41 Histocompatibility Testing Applications Market, By Region, 2019–2025 (USD Million)
Table 42 Blood Profiling Applications Market, By Region, 2019–2025 (USD Million)
Table 43 Post-Transplantation Diagnostics Market, By Region, 2019–2025 (USD Million)
Table 44 Transplant Diagnostics Market for Research Applications, By Region, 2019–2025 (USD Million)
Table 45 Market, By Transplant Type, 2019–2025 (USD Million)
Table 46 Solid Organ Transplantation Market, By Type, 2019–2025 (USD Million)
Table 47 Solid Organ Transplantation Market, By Region, 2019–2025 (USD Million)
Table 48 Kidney Transplantation Market, By Region, 2016–2023 (USD Million)
Table 49 Liver Transplantation Market, By Region, 2016–2023 (USD Million)
Table 50 Lung Transplantation Market, By Region, 2019–2025 (USD Million)
Table 51 Heart Transplantation Market, By Region, 2019–2025 (USD Million)
Table 52 Pancreas Transplantation Market, By Region, 2019–2025 (USD Million)
Table 53 Other Organ Transplantations Market, By Region, 2019–2025 (USD Million)
Table 54 Stem Cell Transplantation Market, By Region, 2019–2025 (USD Million)
Table 55 Soft Tissue Transplantation Market, By Region, 2019–2025 (USD Million)
Table 56 Bone Marrow Transplantation Market, By Region, 2019–2025 (USD Million)
Table 57 Transplant Diagnostics Market, By End User, 2017–2025 (USD Million)
Table 58 Market for Independent Reference Laboratories, By Region, 2017–2025 (USD Million)
Table 59 Market for Hospitals & Transplant Centers, By Region, 2017–2025 (USD Million)
Table 60 Market for Research Laboratories & Academic Institutes, By Region, 2017–2025 (USD Million)
Table 61 Market, By Region, 2017–2025 (USD Million)
Table 62 North America: Transplant Diagnostics Market, By Country, 2017–2025 (USD Million)
Table 63 North America: Market, By Technology, 2017–2025 (USD Million)
Table 64 North America: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 65 North America: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 66 North America: Market, By Product & Service, 2017–2025 (USD Million)
Table 67 North America: Market, By Application, 2017–2025 (USD Million)
Table 68 North America: Market, By Transplant Type, 2017–2025 (USD Million)
Table 69 North America: Transplant Diagnostics Market, By End User, 2017–2025 (USD Million)
Table 70 US: Market, By Technology, 2017–2025 (USD Million)
Table 71 US: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 72 US: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 73 Canada: Market, By Technology, 2017–2025 (USD Million)
Table 74 Canada: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 75 Canada: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 76 Europe: Market, By Country, 2017–2025 (USD Million)
Table 77 Europe: Market, By Technology, 2017–2025 (USD Million)
Table 78 Europe: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 79 Europe: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 80 Europe: Market, By Product & Service, 2017–2025 (USD Million)
Table 81 Europe: Market, By Application, 2017–2025 (USD Million)
Table 82 Europe: Market, By Transplant Type, 2017–2025 (USD Million)
Table 83 Europe: Market, By End User, 2017–2025 (USD Million)
Table 84 Germany: Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 85 Germany: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 86 Germany: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 87 Number of Organ Transplantation Procedures Performed in the UK, 2015 Vs. 2018
Table 88 UK: Market, By Technology, 2017–2025 (USD Million)
Table 89 UK: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 90 UK: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 91 France: Market, By Technology, 2017–2025 (USD Million)
Table 92 France: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 93 France: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 94 Spain: Market, By Technology, 2017–2025 (USD Million)
Table 95 Spain: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 96 Spain: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 97 Italy: Market, By Technology, 2017–2025 (USD Million)
Table 98 Italy: Transplant Diagnostics Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 99 Italy: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 100 RoE: Market, By Technology, 2017–2025 (USD Million)
Table 101 RoE: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 102 RoE: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 103 Asia Pacific: Market, By Country, 2017–2025 (USD Million)
Table 104 Asia Pacific: Market, By Technology, 2017–2025 (USD Million)
Table 105 Asia Pacific: Transplant Diagnostics Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 106 Asia Pacific: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 107 Asia Pacific: Market, By Product & Service, 2017–2025 (USD Million)
Table 108 Asia Pacific: Market, By Application, 2017–2025 (USD Million)
Table 109 Asia Pacific: Market, By Transplant Type, 2017–2025 (USD Million)
Table 110 Asia Pacific: Market, By End User, 2017–2025 (USD Million)
Table 111 Number of Organ Transplantation Procedures Performed in China, 2015 Vs. 2018
Table 112 China: Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 113 China: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 114 China: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 115 India: Market, By Technology, 2017–2025 (USD Million)
Table 116 India: Transplant Diagnostics Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 117 India: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 118 Japan: Market, By Technology, 2017–2025 (USD Million)
Table 119 Japan: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 120 Japan: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 121 Australia: Market, By Technology, 2017–2025 (USD Million)
Table 122 Australia: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 123 Australia: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 124 South Korea: Market, By Technology, 2017–2025 (USD Million)
Table 125 South Korea: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 126 South Korea: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 127 RoAPAC: Market, By Technology, 2017–2025 (USD Million)
Table 128 RoAPAC: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 129 RoAPAC: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 130 Latam: Market, By Country, 2017–2025 (USD Million)
Table 131 Latam: Transplant Diagnostics Market, By Technology, 2017–2025 (USD Million)
Table 132 Latam: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 133 Latam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 134 Latam: Market, By Product & Service, 2017–2025 (USD Million)
Table 135 Latam: Market, By Application, 2017–2025 (USD Million)
Table 136 Latam: Market, By Transplant Type, 2017–2025 (USD Million)
Table 137 Latam: Market, By End User, 2017–2025 (USD Million)
Table 138 Brazil: Market, By Technology, 2017–2025 (USD Million)
Table 139 Brazil: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 140 Brazil: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 141 Mexico: Market, By Technology, 2017–2025 (USD Million)
Table 142 Mexico: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 143 Mexico: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 144 Rolatam: Market, By Technology, 2017–2025 (USD Million)
Table 145 Rolatam: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 146 Rolatam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 147 MEA: Market, By Technology, 2017–2025 (USD Million)
Table 148 MEA: Market for Pcr-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 149 MEA: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 150 MEA: Market, By Product & Service, 2017–2025 (USD Million)
Table 151 MEA: Market, By Application, 2017–2025 (USD Million)
Table 152 MEA: Transplant Diagnostics Market, By Transplant Type, 2017–2025 (USD Million)
Table 153 MEA: Market, By End User, 2017–2025 (USD Million)

List of Figures (45 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries: Global Transplant Diagnostics Market
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Market
Figure 5 Data Triangulation Methodology
Figure 6 Reagents & Consumables Will Continue to Dominate the Transplant Diagnostics Market in 2025
Figure 7 Sequence-Specific Oligonucleotide-Pcr Segment Will Dominate the Market in 2025
Figure 8 Kidney Transplantation Segment Accounted for the Largest Share of the Market in 2019
Figure 9 Infectious Disease Testing Segment Dominates the Transplant Diagnostics Market, By Application
Figure 10 Independent Reference Laboratories—the Fastest-Growing End-User Segment in the Market
Figure 11 Geographical Snapshot of the Market
Figure 12 Rising Number of Transplantation Procedures Will Drive the Demand for Transplant Diagnostic Products During the Forecast Period
Figure 13 Pcr-Based Molecular Assays to Dominate the Transplant Diagnostics Market During the Forecast Period
Figure 14 Infectious Disease Testing and Histocompatibility Testing Segments to Witness High Growth in the Asia Pacific Market
Figure 15 Independent Reference Laboratories Will Dominate the Asia Pacific Transplant Diagnostics End-User Market in 2019
Figure 16 North America Was the Largest Market for All Products & Services in 2019
Figure 17 Kidney Transplantation Segment to Dominate the Transplant Diagnostics Market During the Forecast Period
Figure 18 China is Estimated to Be the Fastest-Growing Market
Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Number of Kidney Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 21 Number of Liver Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 22 Number of Lung Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 23 Number of Heart Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 24 Number of Pancreas Transplantation Procedures in Major Countries, 2013 Vs. 2018
Figure 25 North America: Transplant Diagnostics Market Snapshot
Figure 26 Solid Organ Transplantations Performed in the Us, 2015–2019
Figure 27 Solid Organ Transplantation Procedures Performed in Canada, 2015–2018
Figure 28 Europe: Market Snapshot
Figure 29 Asia Pacific: Market Snapshot
Figure 30 Number of Solid Organ Transplantation Procedures Performed in Japan, 2015–2018
Figure 31 Key Growth Strategies Adopted By Market Players From 2016 to 2019
Figure 32 Bio-Rad Laboratories Held the Leading Position in the Transplant Diagnostics Market
Figure 33 Market: Competitive Leadership Mapping, 2019
Figure 34 Becton, Dickinson and Company: Company Snapshot (2019)
Figure 35 Biomérieux Sa: Company Snapshot (2018)
Figure 36 Bio-Rad Laboratories: Company Snapshot (2018)
Figure 37 Caredx: Company Snapshot (2018)
Figure 38 F. Hoffman-La Roche Limited: Company Snapshot (2018)
Figure 39 Hologic, Inc.: Company Snapshot (2019)
Figure 40 Illumina, Inc.: Company Snapshot (2018)
Figure 41 Immucor, Inc.: Company Snapshot (2016)
Figure 42 Luminex Corporation: Company Snapshot (2018)
Figure 43 Merck KGaA: Company Snapshot (2018)
Figure 44 Qiagen Nv: Company Snapshot (2018)
Figure 45 Thermo Fisher Scientific: Company Snapshot (2018)



★調査レポート[移植診断の世界市場予測:技術別(PCR、NGS、サンガーシーケンス)、製品別(機器、試薬、ソフトウェア)、用途別(HLA、血液像、病原体検出)、種類別(心臓、腎臓、肝臓、骨髄)、エンドユーザー別(病院)] ( Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025 / MD 4870) 販売に関する免責事項
[移植診断の世界市場予測:技術別(PCR、NGS、サンガーシーケンス)、製品別(機器、試薬、ソフトウェア)、用途別(HLA、血液像、病原体検出)、種類別(心臓、腎臓、肝臓、骨髄)、エンドユーザー別(病院)] ( Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025 / MD 4870) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆